The organization of a community: community-based prevention of injecting drug use-related health problems.

The organization of a community: community-based prevention of injecting drug use-related health problems. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The organization of a community: community-based prevention of injecting drug use-related health problems. Abstract Text:

Susan Carruthers,Susan Carruthers,

In the 1980s, injection drug users in Australia mobilized and organized as communities to prevent the transmission of HIV/AIDS, hepatitis C, and other injecting-related harms. This article provides a brief history of the development and role of IDU communities in the prevention of drug use-related harms over the past 20 years and introduces the genesis of a new program that aims to improve peer-based, community-organized prevention and harm reduction initiatives. The project's limitations are noted and future needed research is suggested.

The organization of a community: community-based prevention of injecting drug use-related health problems. Publishing Authors By Initials

S Carruthers,S Carruthers,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The organization of a community: community-based prevention of injecting drug use-related health problems. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Substance use & misuse

VOLUME: 42

Page Numbers: 1971-7

Journal Abbreviation:

ISSN: 1082-6084

DAY: 13

MONTH: 12

YEAR: 2007

The organization of a community: community-based prevention of injecting drug use-related health problems. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9602153

The organization of a community: community-based prevention of injecting drug use-related health problems. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The organization of a community: community-based prevention of injecting drug use-related health problems. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The organization of a community: community-based prevention of injecting drug use-related health problems.

AFFILIATION: Research Fellow, National Drug Research Institute, Curtin University of Technology, Perth, Western Australia.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Subst Use Misuse

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The organization of a community: community-based prevention of injecting drug use-related health problems Related Publications

• 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
• A cleavable propeptide influences Toxoplasma infection by facilitating the trafficking and secretion of the TgMIC2-M2AP invasion complex.
• A transient forward-targeting element for microneme-regulated secretion in Toxoplasma gondii.
• ATP-dependent sugar transport complexity in human erythrocytes.
• Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.
• Broadening discussions of "safe" in hepatitis C prevention: A close-up of swabbing in an analysis of video recordings of injecting practice.
• Caveat emptor (buyer beware).
• Discussion: the history of injectable silicone fluids for soft-tissue augmentation.
• Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores.
• Elderly patients with hypertension should retain 'special' status.
• Endocrine and superovulatory responses in heifers pretreated with FSH or bovine follicular fluid.
• Host cell manipulation by the human pathogen Toxoplasma gondii.
• Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid.
• Laboratory testing of spermicidal preparation.
• Lead identification of acetylcholinesterase inhibitors-histamine H(3) receptor antagonists from molecular modeling.
• MARveling at parasite invasion.
• Mad cows, prions, and wrinkles.
• Malakoplakia: report of a case.
• Patient-reported outcomes with botulinum neurotoxin type A.
• Recent medicinal chemistry of the histamine H3 receptor.
• Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction.
• Shrinking upper and lower eyelid skin with a novel radiofrequency tip.
• Some points in the diagnosis of labyrinthine vertigo and a survey of methods of treatment, medical and surgical.
• Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.
• The J-curve--it is clinically relevant?
• The diagnosis of late life hypogonadism.
• The evolution of botulinum neurotoxin type A for cosmetic applications.
• The organization of a community: community-based prevention of injecting drug use-related health problems.
• The paradox dividing testosterone deficiency symptoms and androgen assays: a closer look at the cellular and molecular mechanisms of androgen action.
• [Not Available.]